Literature DB >> 30464019

Fertility treatment among women with asthma: a case-control study of 3689 women with live births.

Anne Vejen Hansen1, Zarqa Ali1, Sara S Malchau2, Joan Blafoss1, Anja Pinborg2,3, Charlotte S Ulrik1,3.   

Abstract

Asthma has been linked with prolonged time to pregnancy. Our aim was to explore a possible association between asthma and need for fertility treatment among women with live births.All women enrolled in the Management of Asthma during Pregnancy (MAP) programme at Hvidovre Hospital, Denmark were each matched with the next three consecutive women giving birth at Hvidovre Hospital. Information from the Danish National Assisted Reproductive Technology (ART) registry was cross-linked with the Danish Medical Birth registry to identify live births. The primary outcome of interest was births following fertility treatment.Our sample comprised pregnancies from asthmatic mothers (n=932, described as "cases") and non-asthmatic mothers (n=2757, described as "controls"), with 12% (n=114) and 8% (n=212), respectively, having had fertility treatment (OR 1.67, 95% CI 1.32-2.13; p<0.001). This association remained statistically significant after adjusting for confounders, including body mass index (OR 1.31, 95% CI 1.00-1.70; p=0.047). In women ≥35 years, 25% of cases (n=63) and 13% of controls (n=82) received fertility treatment (OR 2.12, 95% CI 1.47-3.07; p<0.001), which also remained statistically significant after adjusting for confounders (OR 1.65, 95% CI 1.11-2.46; p=0.013).A higher proportion of the births from asthmatic mothers involved fertility treatment compared to non-asthmatic mothers, not least among women aged ≥35 years.
Copyright ©ERS 2019.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30464019     DOI: 10.1183/13993003.00597-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

1.  The Danish National Register of assisted reproductive technology: content and research potentials.

Authors:  Line Riis Jølving; Karin Erb; Bente Mertz Nørgård; Jens Fedder; Michael Due Larsen
Journal:  Eur J Epidemiol       Date:  2021-04-01       Impact factor: 8.082

2.  Medication-Wide Association Study Using Electronic Health Record Data of Prescription Medication Exposure and Multifetal Pregnancies: Retrospective Study.

Authors:  Lena Davidson; Silvia P Canelón; Mary Regina Boland
Journal:  JMIR Med Inform       Date:  2022-06-07

Review 3.  Associations Between Asthma and Polycystic Ovary Syndrome: Current Perspectives.

Authors:  Yue Xu; Zhi-Yang Zhou; Jie-Xue Pan; He-Feng Huang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-05       Impact factor: 6.055

4.  Female asthma and atopy - impact on fertility: a systematic review.

Authors:  Joan Bláfoss; Anne Vejen Hansen; Sara S Malchau Lauesgaard; Zarqa Ali; Charlotte Suppli Ulrik
Journal:  J Asthma Allergy       Date:  2019-07-24

5.  Association of Asthma Diagnosis and Medication Use with Fecundability: A Prospective Cohort Study.

Authors:  Holly Michelle Crowe; Lauren Anne Wise; Amelia Kent Wesselink; Kenneth Jay Rothman; Ellen Margrethe Mikkelsen; Henrik Toft Sørensen; Allan Jay Walkey; Elizabeth Elliott Hatch
Journal:  Clin Epidemiol       Date:  2020-06-08       Impact factor: 4.790

6.  Fertility Treatment Resulting in Live Births in Women with Asthma - Associated with Perennial Allergy?

Authors:  Casper Tidemandsen; Anne Vejen Hansen; Vibeke Backer; Elisabeth Juul Gade; Zarqa Ali; Charlotte Suppli Ulrik
Journal:  J Asthma Allergy       Date:  2020-04-24

7.  Treatment with the anti-IgE monoclonal antibody omalizumab in women with asthma undergoing fertility treatment: a proof-of-concept study-The PRO-ART study protocol.

Authors:  Casper Tidemandsen; Elisabeth Juul Gade; Charlotte Suppli Ulrik; Henriette Svarre Nielsen; Birgitte Sophie Oxlund-Mariegaard; Karsten Kristiansen; Nina La Cour Freiesleben; Bugge Nøhr; Hanne Udengaard; Vibeke Backer
Journal:  BMJ Open       Date:  2020-11-12       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.